Related Experiment Video
Updated: Apr 14, 2026

A11-positive β-amyloid Oligomer Preparation and Assessment Using Dot Blotting Analysis
Published on: May 22, 2018
Side Effect of Tris on the Interaction of Amyloid β-peptide with Cu(2+): Evidence for Tris-Aβ-Cu (2+) Ternary Complex
Yannan Bin1, Zhongxiu Jiang, Juan Xiang
1College of Chemistry and Chemical Engineering, Central South University, Changsha, 410083, People's Republic of China.
Abstract:
The interaction of amyloid β-peptide (Aβ) with Cu(2+) is crucial to the development of neurotoxicity in Alzheimer's disease (AD). Many recent studies show a variation on the dissociation constant of Aβ-Cu(2+) under different solvent conditions. Among various buffers, the Tris(hydroxymethyl)aminomethane (Tris) buffer is the most reliable chelator of Cu(2+). However, as a typical nucleophilic reagent capable of binding peptides, the behavior of Tris should be more complicated. In this work, the effect of Tris on the interaction of Aβ with Cu(2+) was investigated. Under acidic conditions, Tris-Aβ-Cu(2+) ternary complex was identified by electrospray ionization mass spectrometry and transmission electron microscopy. The results of surface plasmon resonance reveal that the formation of the ternary complex increases the dissociation constant by almost 1 order of magnitude. Consequently, the assessment of toxicity indicates that the generation of · OH induced by the Aβ-Cu(2+) complex was enhanced in the presence of Tris. The work reveals the significant side effect of Tris on the interaction of Aβ with Cu(2+), which will greatly improve the quantitative investigation on Aβ-Cu(2+) interaction and be helpful for the in-depth understanding of the roles of Aβ and Cu(2+) in AD neuropathology.
More Related Videos
04:41Preparation of Oligomeric β-amyloid1-42 and Induction of Synaptic Plasticity Impairment on Hippocampal Slices
Published on: July 14, 2010
06:27Analysis of β-Amyloid-induced Abnormalities on Fibrin Clot Structure by Spectroscopy and Scanning Electron Microscopy
Published on: November 30, 2018